Podcast: Pituitary adenomas

Today's podcast is the first in an upcoming series of podcasts dedicated to pituitary lesions, with particular attention to pituitary adenomas. Dr. Blevins covers...

Acromegaly: A discussion on medical management and drug combination therapies.

From J D Faccinetti - cofounder -  Recent news coverage from the Endocrine Society Annual Meeting features comments from Maria Fleseriu, MD, FACE, professor...

Ancient Peru, Incas and acromegaly

As some of you may know, my first cousin Carol Mackie Passera, who lives in the Patagonia region of Argentina and who developed acromegaly...

More on the genetics of acromegaly

From Jorge D. Faccinetti - co-founder - The Journal Pituitary published an article on the genetic background of acromegaly.  The Authors, Mônica R. Gadelha, Leandro Kasuki and Márta Korbonits provide a great...

Pseudo-acromegaly: a few comments

From the desk of Lewis S Blevins Jr. MD - cofounder.  I'm not sure this term really exists. It does, however, seem to be...

One person’s POV: The new Somavert delivery system

From J D Faccinetti, cofounder:  The endocrine team at Pfizer delivered some very smart changes to the Somavert injection delivery system, now with a...

From the European Society of Endocrinology: a pituitary update

The European Society of Endocrinology recently published a pituitary update with several interesting presentations. Of particular note, for those of you interested in the genetics...

Discussing the rationale for Pegvisomant dose adjustments

PODCAST:  Listen to this engaging podcast where PWN cofounders Dr. Blevins and JD Faccinetti discuss the ins and outs of a Somavert (pegvisomant for...

Drugs used in the medical treatment of Acromegaly

In this podcats Dr Blevins discussed the drugs used to treat Acromegaly. Among other things, he discusses his perspectives for the proper selection of...

Acromegaly awareness day is November 1

And to mark the occasion we thought it would be fun to participate in the "A Day in my Acromegaly Shoes" initiative. This is a fun...

NEWS YOU CAN USE

Articles you may like